Shattuck Labs (STTK) Assets Average (2020 - 2026)
Shattuck Labs (STTK) reported Assets Average of $96.6 million for Q1 2026, up 14.82% year-over-year from $84.1 million in Q1 2025, and up 0.93% quarter-over-quarter from $95.7 million in Q4 2025.
Shattuck Labs (STTK) Assets Average (2020 - 2026) Analysis & Trends
Shattuck Labs (STTK) has 7 years of Assets Average data on file, last reported at $96.6 million in Q1 2026.
- Assets Average for Q1 2026 came in at $96.6 million, up 14.82% year-over-year; the trailing twelve-month figure through Mar 2026 was $96.6 million (up 14.82% YoY), and the FY2025 annual result was $91.0 million, down 27.35% from the prior year.
- Assets Average improved to $96.6 million in Q1 2026 per STTK's latest filing, from $95.7 million in the prior quarter.
- Over five years, Assets Average peaked at $284.5 million in Q1 2022 and troughed at $70.8 million in Q2 2025.
- A 5-year average of $152.0 million and a median of $142.9 million in 2023 frame the typical range for Assets Average.
- The sharpest annual moves came in 2025 and 2026: Assets Average slumped 48.52% in 2025, then gained 14.82% in 2026.
- A 5-year view of Assets Average shows it stood at $214.1 million in 2022, then tumbled by 32.28% to $145.0 million in 2023, then slumped by 30.08% to $101.4 million in 2024, then decreased by 5.63% to $95.7 million in 2025, then climbed by 0.93% to $96.6 million in 2026.
- Business Quant data shows STTK's Assets Average at $96.6 million in Q1 2026, $95.7 million in Q4 2025, and $82.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 33.42 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 795.91 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13.04 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.72 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 26.03 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 40.89 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 10.06 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 26.06 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 660.38 Mn |
| 10 | Shattuck Labs | 190.32 Mn | 190.32 Mn | - | 96.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 96.57 Mn |
| Dec 31, 2025 | 95.68 Mn |
| Sep 30, 2025 | 82.35 Mn |
| Jun 30, 2025 | 70.77 Mn |
| Mar 31, 2025 | 84.11 Mn |
| Dec 31, 2024 | 101.38 Mn |
| Sep 30, 2024 | 120.17 Mn |
| Jun 30, 2024 | 137.47 Mn |
| Mar 31, 2024 | 152.95 Mn |
| Dec 31, 2023 | 145.01 Mn |
| Sep 30, 2023 | 142.86 Mn |
| Jun 30, 2023 | 166.47 Mn |
| Mar 31, 2023 | 191.50 Mn |
| Dec 31, 2022 | 214.13 Mn |
| Sep 30, 2022 | 237.14 Mn |
| Jun 30, 2022 | 260.92 Mn |
| Mar 31, 2022 | 284.54 Mn |
| Dec 31, 2021 | 304.58 Mn |
| Sep 30, 2021 | 317.17 Mn |
| Jun 30, 2021 | 330.32 Mn |